KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Return on Capital Employed (2019 - 2025)

Moderna (MRNA) has disclosed Return on Capital Employed for 4 consecutive years, with 0.96% as the latest value for Q1 2022.

  • On a quarterly basis, Return on Capital Employed changed N/A to 0.96% in Q1 2022 year-over-year; TTM through Mar 2022 was 0.96%, a N/A change, with the full-year FY2022 number at 0.46%, down 147.0% from a year prior.
  • Return on Capital Employed was 0.96% for Q1 2022 at Moderna, down from 0.97% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.97% in Q4 2021 to a low of 0.48% in Q4 2020.
  • A 4-year average of 0.17% and a median of 0.28% in 2019 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: decreased -4bps in 2020, then surged 145bps in 2021.
  • Moderna's Return on Capital Employed stood at 0.28% in 2019, then plummeted by -72bps to 0.48% in 2020, then soared by 305bps to 0.97% in 2021, then decreased by -1bps to 0.96% in 2022.
  • Per Business Quant, the three most recent readings for MRNA's Return on Capital Employed are 0.96% (Q1 2022), 0.97% (Q4 2021), and 0.48% (Q4 2020).